Fact.MR – A Market Research and Competitive Intelligence Provider: As per a comprehensive study by Fact.MR, the global assisted reproductive technology market is projected to grow at a healthy CAGR of 6.3% between 2020 and 2025.
Assisted Reproductive Technology Demand to Exhibit 1.4X Growth through 2025 as Public Grants Offset High Treatment Cost
Fact.MR’s latest study analyze key trends prevalent across the assisted reproductive technology market. It classifies the market in terms of procedure, technology, and end use. The report is intended at presenting an overview of key driver and opportunities expected to favor the growth trajectory of the market between 2020 and 2025
Fact.MR – A Market Research and Competitive Intelligence Provider: As per a comprehensive study by Fact.MR, the global assisted reproductive technology market is projected to grow at a healthy CAGR of 6.3% between 2020 and 2025.
The growth of the market is largely driven by the increasing number of cases of infertility due to growing stress, obesity, rising dependence on smoking, poly-cystic ovarian syndrome (PCOS) in women, and fertility threatening therapeutics such as chemotherapy.
According to a report by the World Health Organization (WHO), infertility affects nearly 15% of reproductive-aged couples around the world, accounting for nearly 48 million couples and 186 million individuals in 2020.
Thus, the rapid advancement in fertilization technologies and growing awareness regarding novel techniques such as gamete intrafallopian transfer (GIFT) are encouraging couples facing fertility issues to opt for assistive reproductive technologies.
Also, increasing grants to infertility treatment offered by organizations such as Pay-it-Forward Foundation and BabyQuest Foundation are expected to provide high remunerative growth opportunities for the market players.
Fact.MR states that in-vitro fertilization (IVF) is expected to remain the most preferred assisted reproductive technology in the technology segment. This is attributed to the high success rate of the treatment among couples battling infertility.
Innovations in in-vitro fertilization, from preimplantation genetic testing to mitochondrial replacement have resulted in remarkable outcomes. This is expected to make it highly sought-after among technologies available in the assisted reproductive technology market.
“Advancements in assisted reproductive technologies now span the launch of novel fertility drugs to limit the potential side-effects. Coupled with this, integration of machine learning to boost embryo selection has emerged as a pioneering approach, steering growth in the market,” says a lead Fact.MR analyst.
For More Information On How To Improve Your Assisted Reproductive Technology Market Footprint, Request A Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=4393
Key Takeaways from the Assisted Reproductive Technology Market Survey
- The U.S. is anticipated to lead the North America market owing to the increasing number of infertility treatment grants offered by social welfare organizations in the country.
- Favored by the presence of advanced fertility treatment services in the U.K., the country is estimated to exhibit swift growth through the assessment period.
- Fertility treatment boom in China has sealed its position as a market leader in Asia Pacific. The end of one-child policy has provided considerable impetus to the market in China.
- Based on procedure, the fresh non-donor segment is expected to account for a high share in the market.
- In terms of end user, fertility clinics are forecast to dominate the market, accounting for US$ 16.8 billion in 2020 alone.
Key Drivers
- Corporate giants are adopting a number of initiatives to help their employees tackle infertility issues by providing incentives and perks on the storage of their eggs, which in turn is fuelling the demand for frozen donor and frozen non-donor procedures.
- Increasing medical tourism owing to the cost benefits associated with assisted reproductive procedures offered in developing economies such as India and China is accelerating the growth in the Asia Pacific market.
Key Restraints
- High cost of intrauterine insemination (IUI) and in-vitro fertilization procedures are causing a shift in consumer preference from assisted reproductive technology to alternative therapeutics such as naturopathic solutions to treat infertility, which is posing a challenge for the market growth.
- Lack of successive rate and socio-ethical stigma regarding assisted reproductive procedures is hampering the growth of the market.
Ask Your Assisted Reproductive Technology Market Related Questions & Get Customized Reports
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4393
Competitive Landscape
Leading players in the market are focusing on upgrading their existing product lines and engaging into strategic collaboration, merger, acquisition, and agreement with other companies to expand their consumer base and strengthen their footprint in this highly fragmented landscape. For instance,
- In August 2018, GI partners, a company based in the U.S., announced acquiring Cord Blood Registry (CBR) and California Cryobank (CCB), one of the largest private frozen tissue banks in the world. The acquisition was aimed to assist the company for becoming a leading player in reproductive tissue market.
- In April 2019, Monash IVF Group, a fertility research and treatment center based in Australia, announced acquisition of Fertility Solution, a fertility treatment and service provider based in Queensland. The strategy will assist the company to strengthen its presence in the U.K.
Some of the leading players in the market profiled by Fact.MR are:
- California Cryobank
- Bloom IVF Centre
- Parallabs
- OvaScience
- Anecova
- Nidacon International AB
- Origio
- Microm Ltd.
- Merck KGaA
- Ferring Pharmaceuticals
- Boston Science Corporation
- Hamilton Throne Ltd.
More Valuable Insights on Assisted Reproductive Technology Market
Fact.MR, in its new report, offers an unbiased analysis of the global assisted reproductive technology market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in assisted reproductive technology market with detailed segmentation:
By Procedure
- Frozen Donor
- Frozen Non-donor
- Fresh Donor
- Fresh Non-donor
- Embryo Banking
By Technology
- In-vitro Fertilization
- Intra-cytoplasmic Sperm Injection (ICSI)
- Preimplantation Genetic Diagnosis (PGD)
- Surrogacy
- Artificial Insemination
- Intrauterine Insemination (IUI)
- Intracervical Insemination (ICI)
- Others
- Others
By End User
- Fertility Clinics
- Hospitals
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Questions Covered in the Assisted Reproductive Technology Market Report
- The market survey also highlights projected sales growth of the assisted reproductive technology market between 2020 and 2025
- The report offers insight into assisted reproductive technology demand outlook for 2020-2025
- Assisted reproductive technology market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
- Assisted reproductive technology market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Explore Fact.MR’s Coverage on the Healthcare Domain
Assisted Living Market - The rise in the global geriatric population is the primary factor driving the growth of the assisted living market over the forecast period. The growing number of older people who want to retire with their companion and have complete freedom is also driving the growth of the assisted living market. Furthermore, advancements in connected space and smart home technologies are gaining traction in the assisted living market.
Preimplantation Genetic Testing Market - Preimplantation genetic testing is becoming more popular for diagnosing minor disabilities as well as more serious diseases such as cancer. In addition, researchers are focusing on using novel techniques to eliminate the possibility of embryo destruction during preimplantation genetic testing. All of these factors combine to create an ideal environment for preimplantation genetic testing all over the world, and the market is expected to show an impressive valuation by 2031, expanding at a healthy CAGR.
Computer-Assisted Orthopedic Surgery Market - In the medical field, computer-assisted orthopaedic surgery is gaining popularity. This demand is primarily driven by an increase in the number of patients suffering from skeleton and associated disorders. During the forecast period of 2021 to 2031, this is the primary factor driving demand for computer-assisted orthopaedic surgery, along with an increasing older adult population. Advances in technology will play a significant role in the growing demand for computer-assisted orthopaedic surgery by 2031.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR